PRPH ProPhase LabsWatchlist
About ProPhase Labs Company
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $11
HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $14 to $11.
ProPhase Labs Reports Q3 Results
ProPhase Labs Q3 EPS $(0.30) Misses $(0.20) Estimate, Sales $8.37M Miss $13.06M Estimate
ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 600 percent decrease over earnings of $0.06 p
- NIA and Annovis will collaborate to develop pharmacodynamic biomarkers for buntanetap, focusing on isolating brain-derived extracellular vesicles containing potential neuronal function and viability biomarkers. Stock got analyst price target of $37
- Last month the company announced better than expected earnings and announced a dividend. Received Analyst price target of $14.
$JE Cleantech Holdings Limited(JCSE.US)$
- Stock rece...
- Vertex Energy Set To Join Russell 3000 Index June 27. Stock could continue higher pre joining.
- Stock recently broke out. Currently consolidating above $25. Possible another break out soon.
- On Tuesday , Co reported Q1 EPS $0.40 Up From $(0.31) YoY, Sales $98.36M Beat $58.85M Estimate. Stock breaking out.
- NIA and Annovis will collaborate to develop pharmac...